Cargando…
Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease
AIMS: To investigate the impact of established cardiovascular disease (CVD) on 10-year all-cause death following coronary revascularization in patients with complex coronary artery disease (CAD). METHODS: The SYNTAXES study assessed vital status out to 10 years of patients with complex CAD enrolled...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484091/ https://www.ncbi.nlm.nih.gov/pubmed/34432113 http://dx.doi.org/10.1007/s00392-021-01922-y |
_version_ | 1784577243197997056 |
---|---|
author | Wang, Rutao Garg, Scot Gao, Chao Kawashima, Hideyuki Ono, Masafumi Hara, Hironori van Geuns, Robert-Jan Morice, Marie-Claude Davierwala, Piroze M. Kappetein, Arie Pieter Holmes, David R. Wijns, William Tao, Ling Onuma, Yoshinobu Serruys, Patrick W. |
author_facet | Wang, Rutao Garg, Scot Gao, Chao Kawashima, Hideyuki Ono, Masafumi Hara, Hironori van Geuns, Robert-Jan Morice, Marie-Claude Davierwala, Piroze M. Kappetein, Arie Pieter Holmes, David R. Wijns, William Tao, Ling Onuma, Yoshinobu Serruys, Patrick W. |
author_sort | Wang, Rutao |
collection | PubMed |
description | AIMS: To investigate the impact of established cardiovascular disease (CVD) on 10-year all-cause death following coronary revascularization in patients with complex coronary artery disease (CAD). METHODS: The SYNTAXES study assessed vital status out to 10 years of patients with complex CAD enrolled in the SYNTAX trial. The relative efficacy of PCI versus CABG in terms of 10-year all-cause death was assessed according to co-existing CVD. RESULTS: Established CVD status was recorded in 1771 (98.3%) patients, of whom 827 (46.7%) had established CVD. Compared to those without CVD, patients with CVD had a significantly higher risk of 10-year all-cause death (31.4% vs. 21.7%; adjusted HR: 1.40; 95% CI 1.08–1.80, p = 0.010). In patients with CVD, PCI had a non-significant numerically higher risk of 10-year all-cause death compared with CABG (35.9% vs. 27.2%; adjusted HR: 1.14; 95% CI 0.83–1.58, p = 0.412). The relative treatment effects of PCI versus CABG on 10-year all-cause death in patients with complex CAD were similar irrespective of the presence of CVD (p(-interaction) = 0.986). Only those patients with CVD in ≥ 2 territories had a higher risk of 10-year all-cause death (adjusted HR: 2.99, 95% CI 2.11–4.23, p < 0.001) compared to those without CVD. CONCLUSIONS: The presence of CVD involving more than one territory was associated with a significantly increased risk of 10-year all-cause death, which was non-significantly higher in complex CAD patients treated with PCI compared with CABG. Acceptable long-term outcomes were observed, suggesting that patients with established CVD should not be precluded from undergoing invasive angiography or revascularization. TRIAL REGISTRATION: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01922-y. |
format | Online Article Text |
id | pubmed-8484091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84840912021-10-08 Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease Wang, Rutao Garg, Scot Gao, Chao Kawashima, Hideyuki Ono, Masafumi Hara, Hironori van Geuns, Robert-Jan Morice, Marie-Claude Davierwala, Piroze M. Kappetein, Arie Pieter Holmes, David R. Wijns, William Tao, Ling Onuma, Yoshinobu Serruys, Patrick W. Clin Res Cardiol Original Paper AIMS: To investigate the impact of established cardiovascular disease (CVD) on 10-year all-cause death following coronary revascularization in patients with complex coronary artery disease (CAD). METHODS: The SYNTAXES study assessed vital status out to 10 years of patients with complex CAD enrolled in the SYNTAX trial. The relative efficacy of PCI versus CABG in terms of 10-year all-cause death was assessed according to co-existing CVD. RESULTS: Established CVD status was recorded in 1771 (98.3%) patients, of whom 827 (46.7%) had established CVD. Compared to those without CVD, patients with CVD had a significantly higher risk of 10-year all-cause death (31.4% vs. 21.7%; adjusted HR: 1.40; 95% CI 1.08–1.80, p = 0.010). In patients with CVD, PCI had a non-significant numerically higher risk of 10-year all-cause death compared with CABG (35.9% vs. 27.2%; adjusted HR: 1.14; 95% CI 0.83–1.58, p = 0.412). The relative treatment effects of PCI versus CABG on 10-year all-cause death in patients with complex CAD were similar irrespective of the presence of CVD (p(-interaction) = 0.986). Only those patients with CVD in ≥ 2 territories had a higher risk of 10-year all-cause death (adjusted HR: 2.99, 95% CI 2.11–4.23, p < 0.001) compared to those without CVD. CONCLUSIONS: The presence of CVD involving more than one territory was associated with a significantly increased risk of 10-year all-cause death, which was non-significantly higher in complex CAD patients treated with PCI compared with CABG. Acceptable long-term outcomes were observed, suggesting that patients with established CVD should not be precluded from undergoing invasive angiography or revascularization. TRIAL REGISTRATION: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-021-01922-y. Springer Berlin Heidelberg 2021-08-25 2021 /pmc/articles/PMC8484091/ /pubmed/34432113 http://dx.doi.org/10.1007/s00392-021-01922-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Wang, Rutao Garg, Scot Gao, Chao Kawashima, Hideyuki Ono, Masafumi Hara, Hironori van Geuns, Robert-Jan Morice, Marie-Claude Davierwala, Piroze M. Kappetein, Arie Pieter Holmes, David R. Wijns, William Tao, Ling Onuma, Yoshinobu Serruys, Patrick W. Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
title | Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
title_full | Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
title_fullStr | Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
title_full_unstemmed | Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
title_short | Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
title_sort | impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484091/ https://www.ncbi.nlm.nih.gov/pubmed/34432113 http://dx.doi.org/10.1007/s00392-021-01922-y |
work_keys_str_mv | AT wangrutao impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT gargscot impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT gaochao impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT kawashimahideyuki impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT onomasafumi impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT harahironori impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT vangeunsrobertjan impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT moricemarieclaude impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT davierwalapirozem impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT kappeteinariepieter impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT holmesdavidr impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT wijnswilliam impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT taoling impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT onumayoshinobu impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease AT serruyspatrickw impactofestablishedcardiovasculardiseaseon10yeardeathaftercoronaryrevascularizationforcomplexcoronaryarterydisease |